{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:50:34Z","timestamp":1789527034925,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2014.89","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T14:15:46Z","timestamp":1418393746000},"page":"e269-e269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells"],"prefix":"10.1038","volume":"4","author":[{"given":"M","family":"Askmyr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"\u00c5gerstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lilljebj\u00f6rn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"von Palffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Landberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"H\u00f6gberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ehinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"J\u00e4r\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Fioretos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"BFbcj201489_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031\u20131037.","journal-title":"N Engl J Med"},{"key":"BFbcj201489_CR2","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408\u20132417.","journal-title":"N Engl J Med"},{"key":"BFbcj201489_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ . Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest 2011; 121: 396\u2013409.","journal-title":"J Clin Invest"},{"key":"BFbcj201489_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science 1990; 247: 824\u2013830.","journal-title":"Science"},{"key":"BFbcj201489_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S Li","year":"1999","unstructured":"Li S, Ilaria RL Jr, Million RP, Daley GQ, Van Etten RA . The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999; 189: 1399\u20131412.","journal-title":"J Exp Med"},{"key":"BFbcj201489_CR6","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1182\/blood-2003-03-0768","volume":"102","author":"CS Huettner","year":"2003","unstructured":"Huettner CS, Koschmieder S, Iwasaki H, Iwasaki-Arai J, Radomska HS, Akashi K et al. Inducible expression of BCR\/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome. Blood 2003; 102: 3363\u20133370.","journal-title":"Blood"},{"key":"BFbcj201489_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","volume":"105","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, Gottgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 2005; 105: 324\u2013334.","journal-title":"Blood"},{"key":"BFbcj201489_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA . The hallmarks of cancer. Cell 2000; 100: 57\u201370.","journal-title":"Cell"},{"key":"BFbcj201489_CR9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.V91.2.630","volume":"91","author":"ID Lewis","year":"1998","unstructured":"Lewis ID, McDiarmid LA, Samels LM, To LB, Hughes TP . Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD\/SCID mice using blood-derived mononuclear or CD34+ cells. Blood 1998; 91: 630\u2013640.","journal-title":"Blood"},{"key":"BFbcj201489_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.leu.2403649","volume":"19","author":"W Eisterer","year":"2005","unstructured":"Eisterer W, Jiang X, Christ O, Glimm H, Lee KH, Pang E et al. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia 2005; 19: 435\u2013441.","journal-title":"Leukemia"},{"key":"BFbcj201489_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/sj.leu.2403650","volume":"19","author":"Y Chalandon","year":"2005","unstructured":"Chalandon Y, Jiang X, Christ O, Loutet S, Thanopoulou E, Eaves A et al. BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Leukemia 2005; 19: 442\u2013448.","journal-title":"Leukemia"},{"key":"BFbcj201489_CR12","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","volume":"116","author":"A Rizo","year":"2010","unstructured":"Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R et al. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Blood 2010; 116: 4621\u20134630.","journal-title":"Blood"},{"key":"BFbcj201489_CR13","doi-asserted-by":"crossref","unstructured":"Theocharides AP, Dobson SM, Laurenti E, Notta F, Voisin V, Cheng PY et al. Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts. Leukemia 2014 (e-pub ahead of print 5 May 2014).","DOI":"10.1038\/leu.2014.150"},{"key":"BFbcj201489_CR14","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nm.3364","volume":"19","author":"DS Krause","year":"2013","unstructured":"Krause DS, Fulzele K, Catic A, Sun CC, Dombkowski D, Hurley MP et al. Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat Med 2013; 19: 1513\u20131517.","journal-title":"Nat Med"},{"key":"BFbcj201489_CR15","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1182\/blood-2009-05-217182","volume":"116","author":"H Agerstam","year":"2010","unstructured":"Agerstam H, Jaras M, Andersson A, Johnels P, Hansen N, Lassen C et al. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice. Blood 2010; 116: 2103\u20132111.","journal-title":"Blood"},{"key":"BFbcj201489_CR16","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program. Leukemia 2003; 17: 2318\u20132357.","journal-title":"Leukemia"},{"key":"BFbcj201489_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods 2001; 25: 402\u2013408.","journal-title":"Methods"},{"key":"BFbcj201489_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/leu.2013.324","volume":"28","author":"H Lilljebjorn","year":"2014","unstructured":"Lilljebjorn H, Agerstam H, Orsmark-Pietras C, Rissler M, Ehrencrona H, Nilsson L et al. RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D\/CSF1R fusion responsive to imatinib. Leukemia 2014; 28: 977\u2013979.","journal-title":"Leukemia"},{"key":"BFbcj201489_CR19","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL . TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14: R36.","journal-title":"Genome Biol"},{"key":"BFbcj201489_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28: 511\u2013515.","journal-title":"Nat Biotechnol"},{"key":"BFbcj201489_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201489_CR22","doi-asserted-by":"publisher","first-page":"16280","DOI":"10.1073\/pnas.1004408107","volume":"107","author":"M Jaras","year":"2010","unstructured":"Jaras M, Johnels P, Hansen N, Agerstam H, Tsapogas P, Rissler M et al. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein. Proc Natl Acad Sci USA 2010; 107: 16280\u201316285.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201489_CR23","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1182\/blood-2009-10-249326","volume":"115","author":"F Notta","year":"2010","unstructured":"Notta F, Doulatov S, Dick JE . Engraftment of human hematopoietic stem cells is more efficient in female NOD\/SCID\/IL-2Rgc-null recipients. Blood 2010; 115: 3704\u20133707.","journal-title":"Blood"},{"key":"BFbcj201489_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.beha.2010.07.003","volume":"23","author":"P Valent","year":"2010","unstructured":"Valent P, Cerny-Reiterer S, Herrmann H, Mirkina I, George TI, Sotlar K et al. Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells. Best Pract Res Clin Haematol 2010; 23: 369\u2013378.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFbcj201489_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0165-2478(97)00052-7","volume":"57","author":"E Meffre","year":"1997","unstructured":"Meffre E, LeDeist F, de Saint-Basile G, Deville A, Fougereau M, Fischer A et al. A non-XLA primary deficiency causes the earliest known defect of B cell differentiation in humans: a comparison with an XLA case. Immunol Lett 1997; 57: 93\u201399.","journal-title":"Immunol Lett"},{"key":"BFbcj201489_CR26","doi-asserted-by":"publisher","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","volume":"271","author":"RL Ilaria Jr","year":"1996","unstructured":"Ilaria RL Jr ., Van Etten RA . P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 1996; 271: 31704\u201331710.","journal-title":"J Biol Chem"},{"key":"BFbcj201489_CR27","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1182\/blood-2005-09-3596","volume":"107","author":"A Hoelbl","year":"2006","unstructured":"Hoelbl A, Kovacic B, Kerenyi MA, Simma O, Warsch W, Cui Y et al. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 2006; 107: 4898\u20134906.","journal-title":"Blood"},{"key":"BFbcj201489_CR28","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1182\/blood-2013-07-517847","volume":"123","author":"CI Kobayashi","year":"2014","unstructured":"Kobayashi CI, Takubo K, Kobayashi H, Nakamura-Ishizu A, Honda H, Kataoka K et al. The IL-2\/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells. Blood 2014; 123: 2540\u20132549.","journal-title":"Blood"},{"key":"BFbcj201489_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang B, Ho YW, Huang Q, Maeda T, Lin A, Lee SU et al. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 2012; 21: 577\u2013592.","journal-title":"Cancer Cell"},{"key":"BFbcj201489_CR30","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1158\/0008-5472.CAN-13-2797","volume":"74","author":"A Levescot","year":"2014","unstructured":"Levescot A, Flamant S, Basbous S, Jacomet F, Feraud O, Anne Bourgeois E et al. BCR-ABL-induced deregulation of the IL-33\/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients. Cancer Res 2014; 74: 2669\u20132676.","journal-title":"Cancer Res"},{"key":"BFbcj201489_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.thj.6200051","volume":"1","author":"F Dazzi","year":"2000","unstructured":"Dazzi F, Hasserjian R, Gordon MY, Boecklin F, Cotter F, Corbo M et al. Normal and chronic phase CML hematopoietic cells repopulate NOD\/SCID bone marrow with different kinetics and cell lineage representation. Hematol J 2000; 1: 307\u2013315.","journal-title":"Hematol J"},{"key":"BFbcj201489_CR32","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1182\/blood.V92.12.4758","volume":"92","author":"N Takahashi","year":"1998","unstructured":"Takahashi N, Miura I, Saitoh K, Miura AB . Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 1998; 92: 4758\u20134763.","journal-title":"Blood"},{"key":"BFbcj201489_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1182\/blood-2009-12-256800","volume":"116","author":"A Kreutzman","year":"2010","unstructured":"Kreutzman A, Juvonen V, Kairisto V, Ekblom M, Stenke L, Seggewiss R et al. Mono\/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy. Blood 2010; 116: 772\u2013782.","journal-title":"Blood"},{"key":"BFbcj201489_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1600-0609.2010.01501.x","volume":"85","author":"P Rohon","year":"2010","unstructured":"Rohon P, Porkka K, Mustjoki S . Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy. Eur J Haematol 2010; 85: 387\u2013398.","journal-title":"Eur J Haematol"},{"key":"BFbcj201489_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ajh.23626","volume":"89","author":"M Chandia","year":"2014","unstructured":"Chandia M, Corrales A, Castellanos M, Matarraz S, Barrena S, Orfao A . Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene. Am J Hematol 2014; 89: 288\u2013294.","journal-title":"Am J Hematol"},{"key":"BFbcj201489_CR36","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","volume":"120","author":"R Hehlmann","year":"2012","unstructured":"Hehlmann R . How I treat CML blast crisis. Blood 2012; 120: 737\u2013747.","journal-title":"Blood"},{"key":"BFbcj201489_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/1044-5323(95)90043-8","volume":"7","author":"A Rolink","year":"1995","unstructured":"Rolink A, Ghia P, Grawunder U, Haasner D, Karasuyama H, Kalberer C et al. In vitro analyses of mechanisms of B-cell development. Semin Immunol 1995; 7: 155\u2013167.","journal-title":"Semin Immunol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201489","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:54:57Z","timestamp":1672959297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12]]}},"alternative-id":["BFbcj201489"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2014.89","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]},"assertion":[{"value":"27 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}